MEMORIAL HEALTHCARE SYSTEM

Bispecific Antibodies Transform Lung Cancer Treatment Landscape: Amivantamab and Tarlatamab Show Promising Results

5 months ago

Two groundbreaking bispecific antibodies, amivantamab and tarlatamab, are demonstrating significant advances in lung cancer treatment. Amivantamab, in combination with lazertinib, showed superior progression-free survival in NSCLC patients compared to standard therapy, while tarlatamab achieved notable response rates in previously treated SCLC patients, offering new hope in aggressive disease management.

Real-World Study Confirms High Effectiveness of RSV Vaccines in Older Adults

5 months ago

• A real-world study among older US veterans showed RSV vaccines are highly effective against infection, ED/UC visits, and hospitalization. • The study found vaccine effectiveness of 78% against RSV infection, 79% against ED/UC visits, and 80% against hospital admissions. • Vaccine effectiveness against RSV infection was 72.3% in veterans aged 80 years and older and 71.6% in those with weakened immune systems. • The findings support current recommendations for RSV vaccination in adults aged 60 years and older, with updated CDC guidance for the 2024-2025 season.

ASCO Seeks to Expand Pharmacist Membership and Engagement in Oncology Standards Development

7 months ago

• ASCO reports that pharmacists currently make up 1.5% of its 50,000+ members, with leadership actively seeking to increase pharmacist participation in the organization. • Pharmacists have played crucial roles in developing key oncology standards, including the ASCO/NCODA Medically Integrated Pharmacy Standards and ASCO/ONS Antineoplastic Administration Safety Standards. • ASCO leadership acknowledges the need to provide pharmacy continuing education credits at future annual meetings to better serve and attract pharmacist participants.